Cancer Stem Cell & Oncology Research

Recent Advances in Cancer Stem Cell

Cancer stem cells are one of the causes for the relapse of cancer cells and metastasis. They have drug confrontation in contradiction of most chemotherapeutic agents. Cancer stem cells are also liable for tumor cell heterogeneity and cause negligible residual disease. In order to attain whole deterioration of tumors, cscs have to be targeted. Current developments in immunotherapies have shown promising outcomes in preserving cancer, which are also relevant to target Cancer stem cells. Cscs express immune indicators and display precise immune appearances in numerous cancers, which can be used in immunotherapies to mark cscs in the tumor microenvironment. Lately, numerous policies have been used to target cscs. Adaptive T-cells, dendritic cell (DC)-based vaccines, oncotic viruses, immune checkpoint inhibitors, and combination therapies are now being used to target cscs.

<p justify;"="">